Literature DB >> 3460093

Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells.

A C Eaves, J D Cashman, L A Gaboury, D K Kalousek, C J Eaves.   

Abstract

Previous studies have shown that Philadelphia (Ph1) chromosome-positive chronic myeloid leukemia (CML) results from the abnormal expansion at the pluripotent stem cell level of a single clone of hemopoietic cells. Although it seems likely that this is related to the heightened proliferative activity characteristic of primitive CML progenitor cell types, the underlying mechanism is unknown. In this report we show that either normal or CML peripheral blood progenitors can be maintained on preestablished normal marrow adherent layers for periods of 1-2 months. Under these conditions numbers of both normal and neoplastic progenitors are usually higher in the adherent layer than in the nonadherent fraction. Moreover, the number of primitive progenitors of high proliferative potential present in the adherent layer is sufficient to allow their cycling status to be determined. Such measurements demonstrate that primitive normal progenitors of blood origin, when cultured in the presence of a preestablished adherent marrow feeder layer, go in and out of cycle after each medium change but in the absence of a feeder layer remain continuously in cycle. In contrast, primitive CML progenitors of either blood or marrow origin cycle continuously regardless of the presence or absence of an adherent feeder layer. We suggest that early expansion of the CML clone is related to an ability of the neoplastic stem cells to ignore or overcome a negative regulatory signal produced by nonneoplastic adherent marrow cells whose normal function is to maintain the stem cell reserve in a quiescent state.

Entities:  

Mesh:

Year:  1986        PMID: 3460093      PMCID: PMC323940          DOI: 10.1073/pnas.83.14.5306

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer.

Authors:  L Coulombel; A C Eaves; C J Eaves
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

Review 2.  Cell lineages in hematopoietic neoplasia studied with glucose-6-phosphate dehydrogenase cell markers.

Authors:  P J Fialkow
Journal:  J Cell Physiol Suppl       Date:  1982

3.  Pluripotent, erythrocytic and granulocytic hemopoietic precursors in chronic granulocytic leukemia.

Authors:  H Hara; S Kai; M Fushimi; S Taniwaki; H Ifuku; T Okamoto; Y Ohe; S Fujita; K Noguchi; A Kanamaru; K Nagai; E Inada
Journal:  Exp Hematol       Date:  1981-09       Impact factor: 3.084

4.  The regulation of hemopoiesis in long-term bone marrow cultures. II. Stimulation and inhibition of stem cell proliferation.

Authors:  D Toksöz; T M Dexter; B I Lord; E G Wright; L G Lajtha
Journal:  Blood       Date:  1980-06       Impact factor: 22.113

5.  Megakaryocyte cultures in the chronic phase and in the blast crisis of chronic myeloid leukaemia: studies on the differentiation of the megakaryocyte progenitors and on the maturation of megakaryocytes in vitro.

Authors:  W Vainchenker; J Guichard; J F Deschamps; J Bouguet; M Titeux; J Chapman; A J McMichael; J Breton-Gorius
Journal:  Br J Haematol       Date:  1982-05       Impact factor: 6.998

6.  Polycythemia vera: studies of hemopoiesis in continuous long-term culture of human marrow.

Authors:  J S Powell; P J Fialkow; J W Adamson
Journal:  J Cell Physiol Suppl       Date:  1982

7.  Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.

Authors:  L Coulombel; D K Kalousek; C J Eaves; C M Gupta; A C Eaves
Journal:  N Engl J Med       Date:  1983-06-23       Impact factor: 91.245

8.  Pluripotent hemopoietic progenitors (CFU-GEMM) in chronic myelogenous leukemia.

Authors:  J Lepine; H A Messner
Journal:  Int J Cell Cloning       Date:  1983-09

9.  Cytogenetic studies of early myeloid progenitor compartments in Ph1-positive chronic myeloid leukaemia (CML). I. Persistence of Ph1-negative committed progenitors that are suppressed from differentiating in vivo.

Authors:  I D Dubé; C M Gupta; D K Kalousek; C J Eaves; A C Eaves
Journal:  Br J Haematol       Date:  1984-04       Impact factor: 6.998

10.  Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells.

Authors:  D Metcalf; N A Nicola
Journal:  J Cell Physiol       Date:  1983-08       Impact factor: 6.384

View more
  21 in total

1.  Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.

Authors:  J R McWhirter; J Y Wang
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

2.  Differential effects of microenvironmentally presented interleukin 3 versus soluble growth factor on primitive human hematopoietic cells.

Authors:  T Otsuka; J D Thacker; C J Eaves; D E Hogge
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

3.  Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.

Authors:  R Bhatia; E A Wayner; P B McGlave; C M Verfaillie
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

4.  Unregulated proliferation of primitive neoplastic progenitor cells in long-term polycythemia vera marrow cultures.

Authors:  J D Cashman; C J Eaves; A C Eaves
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

5.  Differentiation of the rat myelomonocytic leukemia cell line c-WRT-7 by in vitro culture with the rat bone marrow preadipocyte cell line REC A16.

Authors:  T Tanaka; S Okamura; S Yasumoto; N Takeichi; H Kobayashi; Y Niho
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

6.  Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.

Authors:  C Udomsakdi; C J Eaves; B Swolin; D S Reid; M J Barnett; A C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

7.  An in vitro model for cytogenetic conversion in CML. Interferon-alpha preferentially inhibits the outgrowth of malignant stem cells preserved in long-term culture.

Authors:  J J Cornelissen; R E Ploemacher; B W Wognum; A Borsboom; H C Kluin-Nelemans; A Hagemeijer; B Löwenberg
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha.

Authors:  R Bhatia; P B McGlave; C M Verfaillie
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

9.  Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation.

Authors:  R W Hurley; J B McCarthy; C M Verfaillie
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

10.  Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.

Authors:  S Chu; T McDonald; R Bhatia
Journal:  Leukemia       Date:  2010-03-04       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.